COVID-19 Impact on Global Lacosamide Market Size, Status and Forecast 2020-2026

July 2020 | 94 pages | ID: CDE91D18DC1CEN
QYResearch

Abstracts

This report focuses on the global Lacosamide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lacosamide development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• UCB
• Teva
• Amneal Pharmaceuticals
• MSN Laboratories
• Alembic Pharma
• Glenmark
• Aurobindo Pharma
• Accord Healthcare
• Mylan
• Sun Pharma
• Apotex

Market segment by Type, the product can be split into

• Oral tablets
• Oral solution
• Intravenous

Market segment by Application, split into

• Adults
• Pediatric patients

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Lacosamide status, future forecast, growth opportunity, key market and key players.
• To present the Lacosamide development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Lacosamide are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lacosamide Revenue
1.4 Market Analysis by Type
  1.4.1 Global Lacosamide Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral tablets
  1.4.3 Oral solution
  1.4.4 Intravenous
1.5 Market by Application
  1.5.1 Global Lacosamide Market Share by Application: 2020 VS 2026
  1.5.2 Adults
  1.5.3 Pediatric patients
1.6 Coronavirus Disease 2019 (Covid-19): Lacosamide Industry Impact
  1.6.1 How the Covid-19 is Affecting the Lacosamide Industry
    1.6.1.1 Lacosamide Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Lacosamide Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Lacosamide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Lacosamide Market Perspective (2015-2026)
2.2 Lacosamide Growth Trends by Regions
  2.2.1 Lacosamide Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Lacosamide Historic Market Share by Regions (2015-2020)
  2.2.3 Lacosamide Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Lacosamide Market Growth Strategy
  2.3.6 Primary Interviews with Key Lacosamide Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Lacosamide Players by Market Size
  3.1.1 Global Top Lacosamide Players by Revenue (2015-2020)
  3.1.2 Global Lacosamide Revenue Market Share by Players (2015-2020)
  3.1.3 Global Lacosamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lacosamide Market Concentration Ratio
  3.2.1 Global Lacosamide Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Lacosamide Revenue in 2019
3.3 Lacosamide Key Players Head office and Area Served
3.4 Key Players Lacosamide Product Solution and Service
3.5 Date of Enter into Lacosamide Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Lacosamide Historic Market Size by Type (2015-2020)
4.2 Global Lacosamide Forecasted Market Size by Type (2021-2026)

5 LACOSAMIDE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Lacosamide Market Size by Application (2015-2020)
5.2 Global Lacosamide Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Lacosamide Market Size (2015-2020)
6.2 Lacosamide Key Players in North America (2019-2020)
6.3 North America Lacosamide Market Size by Type (2015-2020)
6.4 North America Lacosamide Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Lacosamide Market Size (2015-2020)
7.2 Lacosamide Key Players in Europe (2019-2020)
7.3 Europe Lacosamide Market Size by Type (2015-2020)
7.4 Europe Lacosamide Market Size by Application (2015-2020)

8 CHINA

8.1 China Lacosamide Market Size (2015-2020)
8.2 Lacosamide Key Players in China (2019-2020)
8.3 China Lacosamide Market Size by Type (2015-2020)
8.4 China Lacosamide Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Lacosamide Market Size (2015-2020)
9.2 Lacosamide Key Players in Japan (2019-2020)
9.3 Japan Lacosamide Market Size by Type (2015-2020)
9.4 Japan Lacosamide Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Lacosamide Market Size (2015-2020)
10.2 Lacosamide Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lacosamide Market Size by Type (2015-2020)
10.4 Southeast Asia Lacosamide Market Size by Application (2015-2020)

11 INDIA

11.1 India Lacosamide Market Size (2015-2020)
11.2 Lacosamide Key Players in India (2019-2020)
11.3 India Lacosamide Market Size by Type (2015-2020)
11.4 India Lacosamide Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Lacosamide Market Size (2015-2020)
12.2 Lacosamide Key Players in Central & South America (2019-2020)
12.3 Central & South America Lacosamide Market Size by Type (2015-2020)
12.4 Central & South America Lacosamide Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 UCB
  13.1.1 UCB Company Details
  13.1.2 UCB Business Overview and Its Total Revenue
  13.1.3 UCB Lacosamide Introduction
  13.1.4 UCB Revenue in Lacosamide Business (2015-2020))
  13.1.5 UCB Recent Development
13.2 Teva
  13.2.1 Teva Company Details
  13.2.2 Teva Business Overview and Its Total Revenue
  13.2.3 Teva Lacosamide Introduction
  13.2.4 Teva Revenue in Lacosamide Business (2015-2020)
  13.2.5 Teva Recent Development
13.3 Amneal Pharmaceuticals
  13.3.1 Amneal Pharmaceuticals Company Details
  13.3.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Amneal Pharmaceuticals Lacosamide Introduction
  13.3.4 Amneal Pharmaceuticals Revenue in Lacosamide Business (2015-2020)
  13.3.5 Amneal Pharmaceuticals Recent Development
13.4 MSN Laboratories
  13.4.1 MSN Laboratories Company Details
  13.4.2 MSN Laboratories Business Overview and Its Total Revenue
  13.4.3 MSN Laboratories Lacosamide Introduction
  13.4.4 MSN Laboratories Revenue in Lacosamide Business (2015-2020)
  13.4.5 MSN Laboratories Recent Development
13.5 Alembic Pharma
  13.5.1 Alembic Pharma Company Details
  13.5.2 Alembic Pharma Business Overview and Its Total Revenue
  13.5.3 Alembic Pharma Lacosamide Introduction
  13.5.4 Alembic Pharma Revenue in Lacosamide Business (2015-2020)
  13.5.5 Alembic Pharma Recent Development
13.6 Glenmark
  13.6.1 Glenmark Company Details
  13.6.2 Glenmark Business Overview and Its Total Revenue
  13.6.3 Glenmark Lacosamide Introduction
  13.6.4 Glenmark Revenue in Lacosamide Business (2015-2020)
  13.6.5 Glenmark Recent Development
13.7 Aurobindo Pharma
  13.7.1 Aurobindo Pharma Company Details
  13.7.2 Aurobindo Pharma Business Overview and Its Total Revenue
  13.7.3 Aurobindo Pharma Lacosamide Introduction
  13.7.4 Aurobindo Pharma Revenue in Lacosamide Business (2015-2020)
  13.7.5 Aurobindo Pharma Recent Development
13.8 Accord Healthcare
  13.8.1 Accord Healthcare Company Details
  13.8.2 Accord Healthcare Business Overview and Its Total Revenue
  13.8.3 Accord Healthcare Lacosamide Introduction
  13.8.4 Accord Healthcare Revenue in Lacosamide Business (2015-2020)
  13.8.5 Accord Healthcare Recent Development
13.9 Mylan
  13.9.1 Mylan Company Details
  13.9.2 Mylan Business Overview and Its Total Revenue
  13.9.3 Mylan Lacosamide Introduction
  13.9.4 Mylan Revenue in Lacosamide Business (2015-2020)
  13.9.5 Mylan Recent Development
13.10 Sun Pharma
  13.10.1 Sun Pharma Company Details
  13.10.2 Sun Pharma Business Overview and Its Total Revenue
  13.10.3 Sun Pharma Lacosamide Introduction
  13.10.4 Sun Pharma Revenue in Lacosamide Business (2015-2020)
  13.10.5 Sun Pharma Recent Development
13.11 Apotex
  10.11.1 Apotex Company Details
  10.11.2 Apotex Business Overview and Its Total Revenue
  10.11.3 Apotex Lacosamide Introduction
  10.11.4 Apotex Revenue in Lacosamide Business (2015-2020)
  10.11.5 Apotex Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Lacosamide Key Market Segments
Table 2. Key Players Covered: Ranking by Lacosamide Revenue
Table 3. Ranking of Global Top Lacosamide Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lacosamide Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral tablets
Table 6. Key Players of Oral solution
Table 7. Key Players of Intravenous
Table 8. COVID-19 Impact Global Market: (Four Lacosamide Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Lacosamide Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Lacosamide Players to Combat Covid-19 Impact
Table 13. Global Lacosamide Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Lacosamide Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Lacosamide Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Lacosamide Market Share by Regions (2015-2020)
Table 17. Global Lacosamide Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Lacosamide Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Lacosamide Market Growth Strategy
Table 23. Main Points Interviewed from Key Lacosamide Players
Table 24. Global Lacosamide Revenue by Players (2015-2020) (Million US$)
Table 25. Global Lacosamide Market Share by Players (2015-2020)
Table 26. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lacosamide as of 2019)
Table 27. Global Lacosamide by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Lacosamide Product Solution and Service
Table 30. Date of Enter into Lacosamide Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 33. Global Lacosamide Market Size Share by Type (2015-2020)
Table 34. Global Lacosamide Revenue Market Share by Type (2021-2026)
Table 35. Global Lacosamide Market Size Share by Application (2015-2020)
Table 36. Global Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 37. Global Lacosamide Market Size Share by Application (2021-2026)
Table 38. North America Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Lacosamide Market Share (2019-2020)
Table 40. North America Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 41. North America Lacosamide Market Share by Type (2015-2020)
Table 42. North America Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 43. North America Lacosamide Market Share by Application (2015-2020)
Table 44. Europe Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Lacosamide Market Share (2019-2020)
Table 46. Europe Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Lacosamide Market Share by Type (2015-2020)
Table 48. Europe Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Lacosamide Market Share by Application (2015-2020)
Table 50. China Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 51. China Key Players Lacosamide Market Share (2019-2020)
Table 52. China Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 53. China Lacosamide Market Share by Type (2015-2020)
Table 54. China Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 55. China Lacosamide Market Share by Application (2015-2020)
Table 56. Japan Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Lacosamide Market Share (2019-2020)
Table 58. Japan Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Lacosamide Market Share by Type (2015-2020)
Table 60. Japan Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Lacosamide Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Lacosamide Market Share (2019-2020)
Table 64. Southeast Asia Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Lacosamide Market Share by Type (2015-2020)
Table 66. Southeast Asia Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Lacosamide Market Share by Application (2015-2020)
Table 68. India Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 69. India Key Players Lacosamide Market Share (2019-2020)
Table 70. India Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 71. India Lacosamide Market Share by Type (2015-2020)
Table 72. India Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 73. India Lacosamide Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Lacosamide Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Lacosamide Market Share (2019-2020)
Table 76. Central & South America Lacosamide Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Lacosamide Market Share by Type (2015-2020)
Table 78. Central & South America Lacosamide Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Lacosamide Market Share by Application (2015-2020)
Table 80. UCB Company Details
Table 81. UCB Business Overview
Table 82. UCB Product
Table 83. UCB Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 84. UCB Recent Development
Table 85. Teva Company Details
Table 86. Teva Business Overview
Table 87. Teva Product
Table 88. Teva Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 89. Teva Recent Development
Table 90. Amneal Pharmaceuticals Company Details
Table 91. Amneal Pharmaceuticals Business Overview
Table 92. Amneal Pharmaceuticals Product
Table 93. Amneal Pharmaceuticals Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 94. Amneal Pharmaceuticals Recent Development
Table 95. MSN Laboratories Company Details
Table 96. MSN Laboratories Business Overview
Table 97. MSN Laboratories Product
Table 98. MSN Laboratories Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 99. MSN Laboratories Recent Development
Table 100. Alembic Pharma Company Details
Table 101. Alembic Pharma Business Overview
Table 102. Alembic Pharma Product
Table 103. Alembic Pharma Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 104. Alembic Pharma Recent Development
Table 105. Glenmark Company Details
Table 106. Glenmark Business Overview
Table 107. Glenmark Product
Table 108. Glenmark Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 109. Glenmark Recent Development
Table 110. Aurobindo Pharma Company Details
Table 111. Aurobindo Pharma Business Overview
Table 112. Aurobindo Pharma Product
Table 113. Aurobindo Pharma Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 114. Aurobindo Pharma Recent Development
Table 115. Accord Healthcare Business Overview
Table 116. Accord Healthcare Product
Table 117. Accord Healthcare Company Details
Table 118. Accord Healthcare Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 119. Accord Healthcare Recent Development
Table 120. Mylan Company Details
Table 121. Mylan Business Overview
Table 122. Mylan Product
Table 123. Mylan Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 124. Mylan Recent Development
Table 125. Sun Pharma Company Details
Table 126. Sun Pharma Business Overview
Table 127. Sun Pharma Product
Table 128. Sun Pharma Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 129. Sun Pharma Recent Development
Table 130. Apotex Company Details
Table 131. Apotex Business Overview
Table 132. Apotex Product
Table 133. Apotex Revenue in Lacosamide Business (2015-2020) (Million US$)
Table 134. Apotex Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Lacosamide Market Share by Type: 2020 VS 2026
Figure 2. Oral tablets Features
Figure 3. Oral solution Features
Figure 4. Intravenous Features
Figure 5. Global Lacosamide Market Share by Application: 2020 VS 2026
Figure 6. Adults Case Studies
Figure 7. Pediatric patients Case Studies
Figure 8. Lacosamide Report Years Considered
Figure 9. Global Lacosamide Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Lacosamide Market Share by Regions: 2020 VS 2026
Figure 11. Global Lacosamide Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Lacosamide Market Share by Players in 2019
Figure 14. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lacosamide as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Lacosamide Revenue in 2019
Figure 16. North America Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Lacosamide Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. UCB Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 25. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Teva Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 27. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amneal Pharmaceuticals Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 29. MSN Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. MSN Laboratories Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 31. Alembic Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alembic Pharma Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 33. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Glenmark Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 35. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Aurobindo Pharma Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 37. Accord Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Accord Healthcare Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 41. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sun Pharma Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 43. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Apotex Revenue Growth Rate in Lacosamide Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed